Polaryx Therapeutics Inc
PLYX
14 hedge funds and large institutions have $17.1M invested in Polaryx Therapeutics Inc in 2026 Q1 according to their latest regulatory filings, with 14 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
4.79% more ownership
Funds ownership: 0% → 4.79% (+4.8%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.1M |
| 2 |
Millennium Management
New York
|
+$824K |
| 3 |
State Street
Boston,
Massachusetts
|
+$375K |
| 4 |
BlackRock
New York
|
+$265K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$181K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
VCM
1
Vanguard Capital Management
Malvern,
Pennsylvania
| $12.5M | +$10.7M | +1,658,388 | New |
|
|
2
Geode Capital Management
Boston,
Massachusetts
| $1.29M | +$1.1M | +170,673 | New |
|
|
3
Millennium Management
New York
| $964K | +$824K | +127,525 | New |
|
|
VFT
4
Vanguard Fiduciary Trust
Malvern,
Pennsylvania
| $790K | +$675K | +104,556 | New |
|
|
5
State Street
Boston,
Massachusetts
| $439K | +$375K | +58,104 | New |
|
|
6
BlackRock
New York
| $310K | +$265K | +41,012 | New |
|
|
7
Northern Trust
Chicago,
Illinois
| $212K | +$181K | +27,987 | New |
|
8
Bank of America
Charlotte,
North Carolina
| $196K | +$167K | +25,881 | New |
|
9
Goldman Sachs
New York
| $102K | +$87.1K | +13,483 | New |
|
10
UBS Group
Zurich,
Switzerland
| $102K | +$87.1K | +13,479 | New |
|
11
Squarepoint
New York
| $93.8K | +$80.1K | +12,406 | New |
|
|
VGA
12
Vanguard Global Advisers
Malvern,
Pennsylvania
| $47.8K | +$40.8K | +6,318 | New |
|
13
Morgan Stanley
New York
| $41.9K | +$35.8K | +5,543 | New |
|
|
TRCT
14
Tower Research Capital (TRC)
New York
| $13.5K | +$11.5K | +1,781 | New |
|
PLYX Hedge Fund Activity: Q1 2026 in Review
14 of the 8,130 institutional investors tracked by Wall St. Rank reported a position in Polaryx Therapeutics Inc (PLYX) for Q1 2026, worth a combined $17.1M.
Buyers outnumbered sellers: 14 funds opened new PLYX positions and 0 closed out — a net gain of 14 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Geode Capital Management, opening a new position worth an estimated $1.1M.
- 14 institutional investors held Polaryx Therapeutics Inc (PLYX) as of Q1 2026, up from 0 in Q4 2025.
- Funds reported $17.1M of Polaryx Therapeutics Inc stock for Q1 2026.
- 14 funds opened new Polaryx Therapeutics Inc positions in Q1 2026 and 0 closed out, a net change of +14 holders.
- The largest Polaryx Therapeutics Inc buyer in Q1 2026 was Geode Capital Management, an estimated $1.1M added.
Based on aggregated 13F filings for Q1 2026.